Dr. Stablein, President, brings a distinguished record as a statistician to the lead position at The EMMES Corporation. His professional stature is reflected in his many current activities. Dr. Stablein is a statistical editor of the Journal of the National Cancer Institute and a fellow of the American Statistical Society. He serves as a member of the Data and Safety Monitoring Board of the National Institute of Child Health and Human Development Maternal Fetal Medicine Network and is chairman of the National Cancer Institute’s Intramural Data and Safety Monitoring Board. He was appointed by the Secretary of Health and Human Services to serve on the National Advisory Commission on Organ Transplantation. He has over 100 publications to his credit.

After receiving his Ph.D. in biostatistics from the Medical College of Virginia, Dr. Stablein began his career there as an assistant professor in biostatistics. He joined EMMES in 1980 as a staff statistician; in 1992 he became president of the company.

Dr. Stablein has served as Principal Investigator for a pediatric renal transplant registry that involves 100 clinics. In that same capacity he directed a project evaluating AIDS vaccines and an investigation of gastrointestinal cancer, both sponsored by the NIH, and both having more than 50 protocols.

Dr. Stablein’s position as President of The EMMES Corporation provides assurance that the company activities are firmly rooted in a sound scientific base.

Dr. Stablein is an active member of The Biopharmaceutical Applied Statistics Symposium (BASS) and is on the 2005 Program Committee.